Who are we?

The SISAQOL consortium is a multidisciplinary team comprised of leading HRQoL researchers and statisticians, key individuals from various international medical societies, advisory and regulatory bodies, academic societies, pharmaceutical industry, cancer institutes and patient advocacy organizations.

It is crucial that key stakeholders are involved in the expert Consortium, so that the insights gathered from this initiative are technically correct, comprehensive and balanced. It is our hope that with this collaborative work, we will be able to set standards for the analysis of HRQoL and PRO data that will be acceptable to all parties.

Funded by unrestricted, academic educational grants from

Genentech logo
Boehringer ngelheim Logo
EORTC logo

Who are we?

The SISAQOL consortium is a multidisciplinary team comprised of leading HRQoL researchers and statisticians, key individuals from various international medical societies, advisory and regulatory bodies, academic societies, pharmaceutical industry, cancer institutes and patient advocacy organizations.

It is crucial that key stakeholders are involved in the expert Consortium, so that the insights gathered from this initiative are technically correct, comprehensive and balanced. It is our hope that with this collaborative work, we will be able to set standards for the analysis of HRQoL and PRO data that will be acceptable to all parties.

Funded by unrestricted, academic educational grants from

Genentech logo
Boehringer ngelheim Logo
EORTC logo
Name Last Name Affiliation Country
Ethan Basch Lineberger Comprehensive Cancer Center; University of North Carolina USA
Andrew Bottomley EORTC Belgium
Melanie Calvert CPROR, University of Birmingham UK
Alicyn Campbell Genentech USA
Charles Cleeland University of Texas MD Anderson Cancer Center USA
Kim Cocks Adelphi Values UK
Corneel Coens EORTC Belgium
Laurence Collette EORTC Belgium
David Collingridge The Lancet Oncology UK
Nance Devlin Office of Health Economics/University of Melbourne UK
Lien Dorme EORTC Belgium
Amylou Dueck Mayo Clinic USA
Hans-Henning Flechtner Clinic for Child and Adolescent Psychiatry and Psychotherapy, Universität Magdeburg Germany
Carolyn Gotay School of Population and Public Health, University of British Columbia Canada
Ingolf griebsch Boehringer Ingelheim International GmbH Germany
Mogens Gronvold Department of Public Health; Bispebjerg Hospital and University of Copenhagen Denmark
Laura Lee Johnson US Food and Drug Administration (FDA) USA
Madeleine King School of Psychology and Sydney Medical School, University of Sydney Australia
Paul Kluetz US Food and Drug Administration (FDA) USA
Michael Koller Center for Clinical Studies, University Hospital Regensburg Germany
Daniel C Malone College of Pharmacy, University of Arizona USA
Francesca Martinelli EORTC Belgium
Sandra A Mitchell National Cancer Institute (NCI) USA
Jammbe Z Musoro EORTC Belgium
Daniel O’Connor Medicines and Healthcare products Regulatory Agency (MHRA) UK
Kathy Oliver International Brain Tumour Alliance (IBTA) UK
Madeline Pe EORTC Belgium
Elisabeth Piault-Louis Genentech USA
Martine Piccart Institut Jules bordet, Université Libre de Bruxelles Belgium
Chantal Quinten European Centre for Disease Prevention and Control (ECDC) Sweden
Jaap C Reijneveld VU University Medical Center, Department of Neurology & Brain Tumor Center The Netherlands
Christoph Schürmann Institute for Quality and Efficiency in Health Care (IQWIG) Germany
Jeff Sloan Mayo Clinic USA
Ashley Wilder Smith National Cancer Institute (NCI) USA
Katherine M Soltys Health Canada Canada
Rajeshwari Sridhara US Food and Drug Administration (FDA) USA
Martin Taphoorn Leiden University Medical Center/Medical Center Haaglanden The Netherlands
Galina Velikova Leeds Institute of Cancer and Pathology, University of Leeds, St James’s Hospital UK
Name Last Name Affiliation Country
Ethan Basch Lineberger Comprehensive Cancer Center; University of North Carolina, Chapel Hill, NC, USA USA
Hans-Henning Flechtner Clinic for Child and Adolescent Psychiatry and Psychotherapy, Universität Magdeburg Germany
Paul Kluetz Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Martine Piccart Institut Jules bordet, Université Libre de Bruxelles Belgium
Jaap C Reijneveld VU University Medical Center, Department of Neurology & Brain Tumor Center The Netherlands
Katherine M Soltys Health Canada Canada
Martin Taphoorn Leiden University Medical Center/Medical Center Haaglanden The Netherlands
Galina Velikova Leeds Institute of Cancer and Pathology, University of Leeds, St James’s Hospital UK
Name Last Name Affiliation Country
Ethan Basch Lineberger Comprehensive Cancer Center; University of North Carolina, Chapel Hill, NC, USA USA
Andrew Bottomley European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Melanie Calvert Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham UK
Charles Cleeland Department of Symptom Research, University of Texas MD Anderson Cancer Center USA
Nance Devlin Office of Health Economics/University of Melbourne UK
Lien Dorme European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Carolyn Gotay School of Population and Public Health, University of British Columbia Canada
Mogens Gronvold Department of Public Health; Bispebjerg Hospital and University of Copenhagen Denmark
Madeleine King School of Psychology and Sydney Medical School, University of Sydney Australia
Paul Kluetz Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Michael Koller Center for Clinical Studies, University Hospital Regensburg Germany
Daniel C Malone College of Pharmacy, University of Arizona USA
Francesca Martinelli European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Sandra A Mitchell Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute (NCI) USA
Jammbe Z Musoro European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Madeline Pe European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Martine Piccart Institut Jules bordet, Université Libre de Bruxelles Belgium
Christoph Schürmann Institute for Quality and Efficiency in Health Care (IQWIG) Germany
Jeff Sloan Alliance Statistics and Data Center, Mayo Clinic USA
Ashley Wilder Smith Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute (NCI) USA
Martin Taphoorn Leiden University Medical Center/Medical Center Haaglanden The Netherlands
Galina Velikova Leeds Institute of Cancer and Pathology, University of Leeds, St James’s Hospital UK
Name Last Name Affiliation Country
Melanie Calvert Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham UK
Alicyn Campbell Genentech USA
Kim Cocks Adelphi Values UK
Corneel Coens European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Laurence Collette European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Lien Dorme European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Amylou Dueck Alliance Statistics and Data Center, Mayo Clinic USA
Laura Lee Johnson Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Madeleine King School of Psychology and Sydney Medical School, University of Sydney Australia
Michael Koller Center for Clinical Studies, University Hospital Regensburg Germany
Jammbe Z Musoro European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Madeline Pe European Organisation for Research and Treatment of Cancer (EORTC Headquarters) Belgium
Chantal Quinten European Centre for Disease Prevention and Control (ECDC), Surveillance and Response Support Unit, Epidemiological Methods Section Sweden
Christoph Schürmann Institute for Quality and Efficiency in Health Care (IQWIG) Germany
Jeff Sloan Alliance Statistics and Data Center, Mayo Clinic USA
Rajeshwari Sridhara Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Name Last Name Affiliation Country
Laura Lee Johnson Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Paul Kluetz Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Daniel O’Connor Medicines and Healthcare products Regulatory Agency (MHRA) UK
Katherine M Soltys Health Canada Canada
Rajeshwari Sridhara Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA) USA
Name Last Name Affiliation Country
Alicyn Campbell Genentech USA
Ingolf griebsch Boehringer Ingelheim International GmbH Germany
Elisabeth Piault-Louis Genentech, a member of the Roche group USA
Name Last Name Affiliation Country
Kathy Oliver International Brain Tumour Alliance (IBTA) UK

DavidCollingridgeThe Lancet OncologyUK

Name Last Name Affiliation Country